News
Background Patients with end-stage renal disease (ESRD) are often excluded from clinical trials of endovascular thrombectomy (EVT). This study investigated the outcome in these patients. Methods From ...
Introduction/Purpose The eShunt Implant (CereVasc, Inc., Boston, MA, USA) is a novel endovascular cerebrospinal fluid (CSF) shunt developed for the treatment of communicating hydrocephalus. The ...
The Contour is a promising new device designed to treat large-neck intra-cranial aneurysms. We describe a first case of Contour device displacement 18 months after initial treatment. A patient with a ...
Background The long-term follow-up of asymptomatic intracranial hemorrhage (aICH) in patients with acute ischemic stroke after endovascular treatment (EVT) remains controversial. O b j e c t i v e To ...
Introduction The safety and feasibility of intravenous cangrelor use for neuroendovascular procedures needs to be investigated. Aim of Study To investigate safety and feasibility of intravenous ...
Background There is uncertainty regarding the predictors of early neurological deterioration (END) after endovascular thrombectomy in patients with acute ischemic stroke (AIS). Limited studies have ...
Introduction Chronic subdural hematoma (cSDH) is a frequently encountered neurosurgical condition with an anticipated increase in prevalence due to the aging population. Middle meningeal artery ...
Introduction Combining the high-resolution images from a traditional 3D-DSA protocol with the longer CBCT protocol may provide simultaneous visualization of both the device and the vessel content in a ...
Background This study assessed the predictive capability of non-contrast CT (NCCT) in identifying anterior circulation large vessel occlusions (LVO) via application of a deep learning algorithm.
Introduction Glenzocimab is a monoclonal antibody fragment targeting platelet glycoprotein VI, inhibiting platelet activation and aggregation. ACTIMIS study (NCT03803007) described the safety profile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results